apceth Biopharma GmbH, a subsidiary of Hitachi Chemical Co., is a pioneering company in regenerative medicines and a leading and certified Contract Development and Manufacturing Organization for cell and gene therapeutics.
The company has comprehensive expertise in GMP manufacturing of autologous and allogeneic cell types that are either native or genetically modified. It has long-standing experience with various cell products, including mesenchymal stem cells (MSCs), hematopoietic stem cells (HSC), lymphocytes, monocytes, dendritic cells, cord blood derived stem cells, and has the potential to expand to CAR-T and induced pluripotent stem cell (iPSC) technologies.
apceth has successfully obtained manufacturing licenses for cell therapy products for multiple clinical as well as one commercial application. Located centrally in the heart of Europe, apceth can perform efficient and fast supply for patients all over the continent. For further information, please visit www.apceth.com